 Lindsey Westbrook
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Granuloma, Foreign-Body | 1 | 2020 | 8 | 0.630 |
Why?
| | Poloxamer | 1 | 2020 | 10 | 0.620 |
Why?
| | Endoscopy | 1 | 2020 | 322 | 0.510 |
Why?
| | Adenocarcinoma | 4 | 2022 | 928 | 0.390 |
Why?
| | Adenomatous Polyps | 2 | 2024 | 9 | 0.360 |
Why?
| | Colorectal Neoplasms | 4 | 2025 | 876 | 0.340 |
Why?
| | Mucins | 1 | 2025 | 75 | 0.210 |
Why?
| | Neoplasm Invasiveness | 2 | 2022 | 512 | 0.190 |
Why?
| | Lymph Nodes | 1 | 2025 | 514 | 0.180 |
Why?
| | Doxycycline | 1 | 2022 | 62 | 0.180 |
Why?
| | Criminals | 1 | 2022 | 34 | 0.180 |
Why?
| | Smooth Muscle Tumor | 1 | 2020 | 6 | 0.160 |
Why?
| | Genes, APC | 1 | 2020 | 11 | 0.160 |
Why?
| | Schwann Cells | 1 | 2020 | 33 | 0.150 |
Why?
| | Hamartoma | 1 | 2020 | 29 | 0.150 |
Why?
| | Esophagogastric Junction | 1 | 2020 | 55 | 0.150 |
Why?
| | Colonic Neoplasms | 1 | 2022 | 258 | 0.150 |
Why?
| | Esophagus | 1 | 2021 | 262 | 0.150 |
Why?
| | Mucous Membrane | 1 | 2020 | 130 | 0.150 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2019 | 7 | 0.150 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2020 | 74 | 0.150 |
Why?
| | Goblet Cells | 1 | 2019 | 22 | 0.150 |
Why?
| | Lymphoproliferative Disorders | 1 | 2019 | 59 | 0.150 |
Why?
| | Carcinoid Tumor | 1 | 2019 | 21 | 0.140 |
Why?
| | Appendiceal Neoplasms | 1 | 2019 | 28 | 0.140 |
Why?
| | Staining and Labeling | 1 | 2019 | 153 | 0.140 |
Why?
| | Stomach Neoplasms | 1 | 2020 | 128 | 0.140 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2019 | 102 | 0.130 |
Why?
| | Esophageal Neoplasms | 1 | 2021 | 351 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 222 | 0.130 |
Why?
| | Pyrimidines | 1 | 2018 | 532 | 0.110 |
Why?
| | Pyrazoles | 1 | 2018 | 518 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 794 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 984 | 0.090 |
Why?
| | Observer Variation | 2 | 2022 | 358 | 0.080 |
Why?
| | Aged | 5 | 2025 | 26514 | 0.080 |
Why?
| | Middle Aged | 6 | 2025 | 36821 | 0.080 |
Why?
| | Neoplasm Staging | 2 | 2025 | 1492 | 0.070 |
Why?
| | Humans | 13 | 2025 | 147293 | 0.060 |
Why?
| | Female | 9 | 2025 | 80076 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2231 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1518 | 0.060 |
Why?
| | Male | 6 | 2025 | 73950 | 0.050 |
Why?
| | Lymphatic Metastasis | 1 | 2025 | 338 | 0.050 |
Why?
| | Colonic Polyps | 1 | 2024 | 88 | 0.050 |
Why?
| | Pathologists | 1 | 2022 | 19 | 0.040 |
Why?
| | Adult | 5 | 2025 | 41405 | 0.040 |
Why?
| | Colonoscopy | 1 | 2024 | 266 | 0.040 |
Why?
| | Esophagectomy | 1 | 2021 | 136 | 0.040 |
Why?
| | S100 Proteins | 1 | 2020 | 35 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8430 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2022 | 204 | 0.040 |
Why?
| | Incidental Findings | 1 | 2020 | 82 | 0.040 |
Why?
| | Melanins | 1 | 2019 | 16 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 385 | 0.040 |
Why?
| | M Phase Cell Cycle Checkpoints | 1 | 2018 | 23 | 0.040 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2018 | 44 | 0.040 |
Why?
| | Rectum | 1 | 2020 | 183 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 142 | 0.030 |
Why?
| | Reference Standards | 1 | 2019 | 177 | 0.030 |
Why?
| | Fluorescence | 1 | 2019 | 161 | 0.030 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 104 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2019 | 313 | 0.030 |
Why?
| | Colon | 1 | 2020 | 310 | 0.030 |
Why?
| | Genetic Testing | 1 | 2020 | 493 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 680 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 1 | 2018 | 239 | 0.030 |
Why?
| | Cell Cycle | 1 | 2018 | 600 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1093 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 939 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1253 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1730 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2890 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1339 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4383 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2529 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1868 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3565 | 0.020 |
Why?
| | Liver | 1 | 2019 | 1916 | 0.020 |
Why?
| | Apoptosis | 1 | 2018 | 2454 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 11017 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 4130 | 0.020 |
Why?
| | United States | 1 | 2024 | 16313 | 0.010 |
Why?
| | Lung | 1 | 2019 | 4141 | 0.010 |
Why?
| | Vidarabine | 1 | 1983 | 32 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11947 | 0.010 |
Why?
| | Herpes Simplex | 1 | 1983 | 102 | 0.010 |
Why?
| | Young Adult | 1 | 2019 | 14437 | 0.010 |
Why?
| | Mice | 2 | 2018 | 18491 | 0.010 |
Why?
| | Encephalitis | 1 | 1983 | 142 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 17560 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 22825 | 0.010 |
Why?
| | Antiviral Agents | 1 | 1983 | 776 | 0.010 |
Why?
| | Animals | 2 | 2018 | 38410 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1983 | 196 | 0.000 |
Why?
|
|
Westbrook's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|